BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Celyad Oncology

1 post
Celyad-Oncology-Pauses-CYAD-101-002-Keynote-B79-Phase-1-Trial-After-2-Deaths-Reported

Biotech NewsCelyad Oncology Pauses CYAD-101-002 (Keynote-B79) Phase 1 Trial After 2 Deaths Reported

  • BioTech Health X
  • February 28, 2022
Clinical-stage biotechnology company Celyad Oncology (NASDAQ: CYAD) recently announced that the company has voluntarily paused the CYAD-101-002 (KEYNOTE-B79)…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Annovis Bio (ANVS) Raises $6M at $1.50/Share
  • GRI Bio (GRI) Skyrockets 48.72% After NKT Therapy Breakthrough
  • Tyra Biosciences (TYRA): The $274.9M Precision Biotech Betting Big on FGFR3 Breakthroughs in 2026
  • Mobile-Health Network (MNDR) Soars 83% After $120M AI Data Center Deal
  • Nutex Health (NUTX) Posts 220.7% Revenue Surge
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • November 20, 2025
    Annovis Bio (ANVS) Raises $6M at $1.50/Share
    • November 20, 2025
    GRI Bio (GRI) Skyrockets 48.72% After NKT Therapy Breakthrough
    • November 20, 2025
    Tyra Biosciences (TYRA): The $274.9M Precision Biotech Betting Big on FGFR3 Breakthroughs in 2026
    • November 20, 2025
    Mobile-Health Network (MNDR) Soars 83% After $120M AI Data Center Deal
    • November 19, 2025
    Nutex Health (NUTX) Posts 220.7% Revenue Surge
Recent Posts
  • Exact Sciences (EXAS) Soars 25% After Abbott Takeover Rumors
    • November 19, 2025
  • Analysts Cut Earnings Estimates for Agios Pharma (AGIO)—But Some Still Target $56–$57
    • November 19, 2025
  • Catalyst Pharmaceuticals (CPRX) Smashes Earnings With $148.4M Revenue
    • November 19, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (569)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top